CTIS.eu › Cities › Sweden › Lund
Lund
Sweden
308 total trials
142 recruiting
2024-518254-16-00
5
2013-03-01
Acute Myeloid Leukemia (Pediatric 0-18 years)
2025-522598-12-00
10
2025-12-17
Untreated Metastatic Pancreatic Ductal Adenocarcinoma
2025-520520-17-00
5
2025-09-05
Heterozygous familial hypercholesterolaemia
2024-516814-39-00
5
2025-05-20
Chronic rhinosinusitis with nasal polyps
2024-513968-25-00
5
2025-04-28
Metastatic castration-resistant prostate cancer (mCRPC)
2023-505394-32-00
5
2025-02-06
chronic graft versus host disease
2024-518669-83-00
4
2024-12-05
acute promyelocytic leukemia (APL) in children and adolescents
2024-513539-25-00
4
2024-11-22
Type 2 Diabetes Mellitus
2024-512676-36-00
10
2024-10-09
Langerhans Cell Histiocytosis
2023-505892-56-00
5
2024-09-30
Major Depressive Disorder
2023-509182-21-00
4
2024-09-16
Patients with ST-Elevation Myocardial Infarction (STEMI)
2023-510178-15-00
5
2024-07-31
High-risk Large B-cell Lymphoma
2024-512439-54-01
4
2024-07-24
Non-small cell lung cancer (NSCLC)
2023-506335-15-00
5
2024-07-18
Major Depressive Disorder
2023-503755-10-00
5
2024-05-17
Splenic marginal zone lymphoma
2023-506669-70-00
5
2024-04-30
Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM).
2023-506029-12-00
5
2024-04-03
Migraine
2023-504816-14-00
5
2024-03-08
Endometrial cancer
2022-502446-27-00
5
2024-02-26
Relapsed or Refractory Myeloma
2023-505268-12-00
5
2024-02-09
Treatment-resistant depression
2023-509268-26-00
6
2024-01-08
Dyslipidemia
2023-503652-27-00
5
2023-10-06
Melanoma
2022-500100-21-01
4
2023-09-11
Follicular lymphoma
2022-502779-40-00
5
2023-09-04
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
Showing 169–192 of 308 trials